Robert Hart, Forbes Staff

Author's posts

Report: Drop In Greenhouse Gas Emissions Amid Covid-19 Pandemic Fails To Slow Climate Crisis

Despite emissions plummeting during lockdowns, greenhouse gas levels continue to rise to record levels.

AstraZeneca-Oxford Vaccine Up To 90% Effective At Preventing Covid-19, Early Results Show

The vaccine is cheaper and much easier to transport than Pfizer and Moderna’s vaccines, which are 95% effective.

Covid-19 Patients Are ‘Highly Infectious’ Within Five Days Of Showing Symptoms, Study Shows, Explaining Pandemic’s Rapid Spread

Research indicates that the virus is “short-lived” and that patients are no longer infectious after nine days of showing symptoms.

Pfizer, BioNTech To Seek Emergency Approval For Covid-19 Vaccine On Friday

Clinical trials show the vaccine to be 95% effective at preventing Covid-19.

World Health Organization Rejects Remdesivir, The Antiviral Trump Took For Covid-19, Saying There’s No Evidence It Helps Recovery Or Survival

Remdesivir is one of the only drugs approved by the Food and Drug Administration to treat Covid-19.

Denmark Says Mutant Covid-19 Strain From Mink Is ‘Most Likely’ Extinct

After more than 200 people caught mink-related Covid-19, the country ordered the culling of its entire 17-million-strong herd of mink.

Tyson Foods Managers Placed Bets On How Many Workers Would Catch Covid-19, Wrongful Death Lawsuit Alleges

The lawsuit alleges Tyson displayed a “wilful and wanton disregard for worker safety” in a plant where over 1,000 employees caught Covid-19.

Oxford Vaccine Induces ‘Robust’ Immune Response In Older Adults, Early Findings Show

Older adults, who are most at risk from the coronavirus, usually respond less well to vaccines.

Mike Pence Falsely Gives Credit To Trump For Pfizer Vaccine Success

Pfizer has repeatedly said its vaccine research and development is “entirely self-funded.”

Sinovac’s Covid-19 Vaccine Appears Safe And Prompts ‘Quick’ Immune Response, Study Finds

Researchers believe the vaccine, which is already approved in China, could be “suitable for emergency use during the pandemic,” though further clinical trials will be needed.